Neurostimulation Devices Market Size to Reach Valuation of USD 13.70 Billion by 2027 | Increasing Prevalence of Chronic Nervous Disorders and Rising Demand for Minimally Invasive Surgeries is Driving Industry Demand, According to Emergen Research

VANCOUVER, BC, Jan. 12, 2022 /PRNewswire/ -- The global neurostimulation devices market size was USD 5.60 Billion in 2019 and is expected to reach USD 13.70 Billion by 2027 registering a CAGR of 12.6% through the forecast period. The economic development and increasing Healthcare Budgetary Allocation in developing countries is expected to drive the growth of the neurostimulation devices market. Rising focus on shorter hospital stays is fueling the adoption of neurostimulation devices and, in turn, boosting growth of the market.

Further technological advancement coupled with robust investment in the healthcare infrastructure across the globe are encouraging introduction and adoption of newer technologies, which is driving growth of the neurostimulation devices market. Adoption of advanced technologies, including Artificial Intelligence and machine learning, is contributing to the formation of smart neuromodulation, which is benefiting patients suffering from brain damage.

Free Sample PDF Copy of the Report Available@ https://www.emergenresearch.com/request-sample/349

Key Highlights From Report

• In 2019, Medtronic launched the Intellis, a management platform for the chronic intractable pain. It is able to track patients and get real time data over chronic pain.
• In September 2019, U.S. Food and Drug Administration (FDA) approved Abbott's Proclaim XR™ recharge free neurostimulation platform for people living with chronic pain. The approval helped Abbott to secure a higher market share and increase its neurostimulation devices product portfolio.
• The spinal cord stimulator sub-segment acquired the largest market share of 46.2% in 2019. This growth is attributable to the rising need for treatment of spinal injuries and neuropathic pain. This factor is estimated to benefit over the forecast period.
• Pain management sub-segment is projected to expand at a fastest CAGR of 14.0% during the foreseeable future. This growth is attributable to increasing incidence of chronic and acute pain disorders coupled with patients suffering from neurological disorders.
• Regionally, the Asia Pacific region is projected to exhibit the fastest growth over the forecast period. This growth is attributable to the economic development, coupled with increasing Healthcare Budgetary Allocation, especially in emerging economies, is expected to drive the growth of neurostimulation devices in the region.
• Key participants include St. Jude Medical, Boston Scientific Corporation, Medtronic, Neuronetics, Inc., Nevro Corporation, Codman & Shurtleff, Inc., Intrapace, LivaNova plc, Abbott Laboratories, and Bayer AG.
• Deep brain stimulators held the second largest market share of 19.8% in 2019. The rising incidence of neurological disorders among the rising global geriatric population is expected to boost the demand for Deep brain stimulators.
• Urinary and fecal Incontinence is expected to register steady growth over the forecast period. Increasing utilization of the sacral nerve stimulators for the treatment of Urinary and fecal Incontinence is expected to drive the growth of the neurostimulation devices market.   

Special New Year Discount Available on Neurostimulation Devices market report@ https://www.emergenresearch.com/request-discount/349

Emergen Research has segmented the global Neurostimulation Devices Market on the basis of Product, Application, and region:

• Product Outlook (Revenue, USD Billion; 2017-2027)
• Sacral Nerve stimulator
• Spinal Cord Stimulator
• Vagus Nerve Stimulator
• Gastric Electric Stimulators
• Deep Brain Stimulators
• Application Outlook (Revenue, USD Billion; 2017-2027)
• Epilepsy
• Depression
• Dystonia
• Gastroparesis
• Pain management
• Urinary and Fecal Incontinence
• Essential Tremor
• Parkinson's Disease
• Others

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/neurostimulation-devices-market

• Regional Outlook (Revenue, USD Billion; 2017-2027)
• North America
• a.  U.S.
• b.  Canada
• Europe
• a.  Germany
• b.  UK
• c.  France
• d.  BENELUX
• e.  Rest of Europe
• Asia Pacific
• a.  China
• b.  Japan
• c.  South Korea
• d.  Rest of APAC
• Latin America
• a.  Brazil
• b.  Rest of LATAM
• MEA
• a.  Saudi Arabia
• b.  UAE
• c.  Rest of MEA

Buy Your Exclusive Copy@ https://www.emergenresearch.com/select-license/349

Explore Reports offered by Emergen Research:

The global lactase market size reached USD 220.7 Million in 2020, and is expected to register a CAGR of 6.3% during the forecast period. Market revenue growth is primarily driven by increasing number of lactose-intolerant cases around the world coupled with growing concerns regarding digestive issues. Consumers diagnosed with lactose intolerance have difficulty digesting lactose, due to lactase deficiency in the body.

Global food vacuum machine market size reached USD 11.94 Billion in 2020 and is expected to register a CAGR of 4.7% during the forecast period. Changing climatic conditions are resulting in a slow, but sure need for more durable and sterile packaging, which is one among other key factors expected to drive global food vacuum machine market revenue growth over the forecast period.

The global fruit & vegetable processing market size reached USD 304.50 Billion in 2020 and is expected to register a CAGR of 7.3% during the forecast period. Increasing consumer dependency on processed foods due to changing lifestyle among consumers is a key factor expected to continue to drive global fruit & vegetable processing market revenue growth to a significant extent over the forecast period.

The global food enzymes market size is expected to reach USD 3,309.9 Million in 2028, and register a revenue CAGR of 6.1% during the forecast period. Steady market revenue growth can be attributed to rising demand for convenience food.

The global food thickeners market size reached USD 13.61 Billion in 2020 and is expected to register a revenue CAGR of 5.6% during the forecast period. Increasing changes in food preference among consumers is a major factor expected to drive market revenue growth over the forecast period

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com 
Direct Line: +1 (604) 757-9756
E-mail: [email protected] 
Visit for More Insights: https://www.emergenresearch.com/insights 
Explore Our Custom Intelligence services | Growth Consulting Services 
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-neurostimulation-devices-market

SOURCE Emergen Research